Combination therapy based on pegylated interferon alfa improves the therapeutic response of patients with chronic hepatitis B who exhibit high levels of hepatitis B e-antigen at 24 weeks
2014 ◽
Vol 59
(12)
◽
pp. 1714-1723
◽
2011 ◽
Vol 54
(1)
◽
pp. 39-47
◽
2007 ◽
Vol 22
(10)
◽
pp. 1582-1588
◽
2007 ◽
Vol 51
(8)
◽
pp. 3020-3022
◽